Nalaganje...
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
BACKGROUND: High-dose short-term methylprednisolone is the recommended treatment in the management of multiple sclerosis relapses, although it has been suggested that lower doses may be equally effective. Also, glucocorticoids are associated with multiple and often dose-dependent adverse effects. Th...
Shranjeno v:
| izdano v: | BMC Neurol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609048/ https://ncbi.nlm.nih.gov/pubmed/26475456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0450-x |
| Oznake: |
Označite
Brez oznak, prvi označite!
|